Networked Glucose Meter Market Report 2026

The networked glucose meter market size has grown rapidly in recent years. It will grow from $3.12 billion in 2025 to $3.52 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing diabetes prevalence, growing adoption of digital health tools, rising demand for real-time glucose data, expanding acceptance of connected medical devices and increasing usage of smartphones for health monitoring.

The networked glucose meter market size is expected to see rapid growth in the next few years. It will grow to $5.67 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to growing shift toward remote patient monitoring, increasing integration of ai-based diabetes management, rising preference for personalized glucose insights, expansion of cloud-connected healthcare platforms and increasing adoption of wearable glucose monitoring devices. Major trends in the forecast period include technological advancements in continuous glucose monitoring, innovations in multi-sensor wearable devices, developments in cloud-based diabetes analytics, research and development in non-invasive glucose monitoring and advancements in smartphone-integrated health ecosystems.

The increasing prevalence of diabetes is expected to drive the growth of the networked glucose meter market in the coming years. Diabetes is a chronic medical condition in which the body cannot properly regulate blood sugar or glucose levels. This rising prevalence is largely fueled by increasing obesity rates, which heighten the risk of developing type 2 diabetes. Networked glucose meters support diabetes management by continuously monitoring blood glucose levels and transmitting the data to healthcare providers in real time. They enhance patient outcomes by enabling timely interventions, personalized treatment adjustments, and improved overall glycemic control. For example, in April 2025, the UK Parliament, a UK-based parliamentary digital service, reported that the number of people with type 2 diabetes using continuous glucose monitoring increased from 37,000 in 2022-23 to 95,000 in 2023-24, reaching 155,000 in 2024-25. Consequently, the rising prevalence of diabetes is propelling the growth of the networked glucose meter market.

Leading companies in the networked glucose meter market are concentrating on developing advanced products, such as cellular-enabled glucose meters, to enhance chronic care management. Cellular-enabled glucose meters are blood glucose monitoring devices with built-in cellular connectivity, enabling automatic transmission of glucose readings over mobile networks to cloud platforms, healthcare providers, or care management systems. For example, in May 2024, Smart Meter LLC, a US-based provider of cellular remote patient monitoring solutions, launched the iGlucose Plus. This cellular-enabled glucose meter is designed to improve diabetes management by offering real-time data transmission and multi-language support, featuring a color LED screen for clear instructions and on-device notifications for medication and dietary reminders. The solution also includes AI-driven test strip auto-replenishment and over-the-air software updates to promote consistent testing behaviors and enhance long-term health outcomes for patients managing chronic conditions.

In August 2024, Abbott Laboratories, a US-based global healthcare company, partnered with Medtronic plc to integrate Abbott’s continuous glucose monitoring (CGM) systems with Medtronic’s insulin delivery devices. This collaboration aims to advance networked glucose monitoring by enabling seamless data sharing between Abbott’s CGM platforms, such as the FreeStyle Libre system, and Medtronic’s insulin pumps and delivery technologies. Medtronic plc is a US-based medical technology company that designs, develops, manufactures, and markets medical devices and solutions.

Major companies operating in the networked glucose meter market are Abbott Laboratories, Medtronic plc, Dexcom Inc., Nipro Corporation, LifeScan Inc., Ascensia Diabetes Care, Sinocare Inc., Arkray Inc., BeatO, Roche Diabetes Care Ltd., Bionime Corporation, ACON Diabetes Care, i-Sens Inc., Senseonics Holdings, A. Menarini Diagnostics, Dr. Morepen Laboratories Ltd., Sensa Core Medical Instrumentation Pvt. Ltd., MicroTech Medical, Medtrum Technologies, Nemaura Medical, Biochemical Systems International S.p.A., Biolinq, AndesFit Health.

North America was the largest region in the networked glucose meter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the networked glucose meter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the networked glucose meter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the networked glucose meter market by increasing costs of imported sensors, microchips, wireless modules, batteries, and display components. healthcare providers and homecare users in north america and europe are most affected due to reliance on imported electronics, while asia-pacific faces cost pressures on device manufacturing and exports. these tariffs are raising device prices and slowing adoption rates. however, they are also driving local manufacturing, regional component sourcing, and innovation in cost-efficient connected glucose monitoring solutions.

A networked glucose meter is a connected device for monitoring blood glucose that automatically sends glucose readings to smartphones, cloud platforms, or healthcare systems. It allows real-time tracking, remote monitoring, and integration with diabetes management software. These devices facilitate enhanced disease management through continuous data sharing and analysis.

The key product types of networked glucose meters include continuous glucose monitoring systems and traditional glucose meters. Continuous systems provide real-time glucose tracking with data sharing and alerts via Bluetooth, Wi-Fi, cellular, and other connections, distributed through online channels, pharmacies, and healthcare institutions, used by home-care patients, healthcare facilities, and self-monitoring users.

The networked glucose meter market consists of revenues earned by entities by providing services such as remote blood glucose monitoring, real-time data transmission and analysis, personalized diabetes management, alert and notification services, telehealth consultations, cloud-based health data storage, and integration with digital health platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The networked glucose meter market includes sales of connected blood glucose meters, wireless-enabled glucose monitoring devices, test strips and lancets compatible with networked meters, data-syncing accessories, and integrated software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.